Role of surgeon experience in the outcome of transurethral resection of bladder tumors

被引:5
作者
Ali, Mohamed Hassan [1 ]
Eltobgy, Ahmed [1 ]
Ismail, Iman Yehia [1 ]
Ghobish, Ammar [1 ]
机构
[1] Suez Canal Univ, Dept Urol, Fac Med, Round Rd, Ismailia, Egypt
关键词
Quality; Surgeon experience; transurethral resection of bladder tumors; INVASIVE UROTHELIAL CARCINOMA; TRANSITIONAL-CELL CARCINOMA; EVALUATING PATIENTS; DETRUSOR MUSCLE; CANCER; RECURRENCE; RISK; QUALITY; 1ST; METAANALYSIS;
D O I
10.4103/UA.UA_138_19
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The purpose of the study is to assess the quality of transurethral resection of bladder tumors (TURBTs) performed by "senior" and "junior" urologists in terms of detrusor muscle (DM) presence at the initial resection and presence of missed and residual tumors at second-look TURBT. Patients and Methods: An analytic prospective cohort study included 171 patients with stage T1 and Ta bladder cancer who had undergone an initial TURBT. Patients were divided into two groups according to surgeon experience. Group 1 (116 patients) operated on by senior surgeons (consultants and trainees in year 5 or 6) and Group 2 (55 patients) operated on by junior surgeons (trainees below year 5). All patients underwent second-look TURBT (by a senior urologist) within 2-6 weeks after the initial resection. The outcome of the initial and re-TURBT represented with regard to the surgeon experience. Results: There is a statistically significant difference between senior and junior surgeons regarding the presence or absence of DM in the initial resection (P = 0.001). A significant relation between the presence of residual tumors in re thermodynamic uncertainty relation (TUR) in relation to the initial operator was found (P = 0.03). Re-TURBT of patients in Group 1 (initially operated on by experienced surgeons) revealed that 57.7% had tumor-free resection while 36.2% had residual tumors, 5.2% had missed lesion and only 0.9% had concurrent residual and missed tumors. In contrast, from Group 2 (55 patients operated by junior surgeons) 47.3% had residual tumor, 21.8% had missed lesions, and 9.1% had concurrent residual and missed tumors in re-TUR. Conclusions: Nonmuscle invasive bladder cancer treated with TURBT should be managed as any other major oncologic procedure. TURBT should be performed by an experienced surgeon or with very close supervision when done by training urologist.
引用
收藏
页码:341 / 346
页数:6
相关论文
共 28 条
[1]   Evaluation of Second-Look Transurethral Resection in Restaging of Patients with Nonmuscle-Invasive Bladder Cancer [J].
Ali, Mohamed H. ;
Ismail, Iman Y. ;
Eltobgy, Ahmad ;
Gobeish, Ammar .
JOURNAL OF ENDOUROLOGY, 2010, 24 (12) :2047-2050
[2]  
Ali-el-Dein B, 2006, UROL S, V5, P190
[3]   EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 [J].
Babjuk, Marko ;
Boehle, Andreas ;
Burger, Maximilian ;
Capoun, Otakar ;
Cohen, Daniel ;
Comperat, Eva M. ;
Hernandez, Virginia ;
Kaasinen, Eero ;
Palou, Joan ;
Roupret, Morgan ;
van Rhijn, Bas W. G. ;
Shariat, Shahrokh F. ;
Soukup, Viktor ;
Sylvester, Richard J. ;
Zigeuner, Richard .
EUROPEAN UROLOGY, 2017, 71 (03) :447-461
[4]   Second Resection for Non-Muscle-Invasive Bladder Carcinoma: Current Role and Future Perspectives [J].
Babjuk, Marko .
EUROPEAN UROLOGY, 2010, 58 (02) :191-192
[5]   Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies [J].
Brausi, M ;
Collette, L ;
Kurth, K ;
van der Meijden, AP ;
Oosterlinck, W ;
Witjes, JA ;
Newling, D ;
Bouffioux, C ;
Sylvester, RJ .
EUROPEAN UROLOGY, 2002, 41 (05) :523-530
[6]   Dedicated teaching programs can improve the quality of TUR of non-muscle-invasive bladder tumours (NMIBT): Experience of a single institution [J].
Brausi, M. A. ;
Gavioli, M. ;
Peracchia, G. ;
Viola, M. ;
Giliberto, G. L. ;
Simonini, G. ;
De Luca, G. ;
Borelli, A. ;
Bertom, V ;
Verrini, G. .
EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) :180-180
[7]   International Variations in Bladder Cancer Incidence and Mortality [J].
Chavan, Saurabh ;
Bray, Freddie ;
Lortet-Tieulent, Joannie ;
Goodman, Michael ;
Jemal, Ahmedin .
EUROPEAN UROLOGY, 2014, 66 (01) :59-73
[8]   Impact of a second transurethral resection on the staging of T1 bladder cancer [J].
Dalbagni, G ;
Herr, HW ;
Reuter, VE .
UROLOGY, 2002, 60 (05) :822-824
[9]   The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin:: A prospective, randomized clinical trial [J].
Divrik, RT ;
Yildirim, Ü ;
Zorlu, F ;
Özen, H .
JOURNAL OF UROLOGY, 2006, 175 (05) :1641-1644
[10]   Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy [J].
Dutta, SC ;
Smith, JA ;
Shappell, SB ;
Coffey, CS ;
Chang, SS ;
Cookson, MS .
JOURNAL OF UROLOGY, 2001, 166 (02) :490-493